The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for WaveRise Investments Ltd

July 29, 2026 1. BSE Limited The Secretary BSE Limited, Phiroze Jeejeebhoy Towers, Mumbai - 400 001 Scrip Code: 500672 2. Novartis India Limited Inspire BKC, 7th Floor Bandra Kurla Complex Bandra East, Mumbai 400051 Maharashtra, India Sub: Disclosure under Regulation 29(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended. We, WaveRise Investments Limited, ChrysCapital Fund X and Two Infinity Partners (collectively the Acquirers 29(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended. We request you to kindly take the above on record and acknowledge receipt. Sincerely, [Signature pages to follow] Disclosures under Regulation 29(1) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Part-A - Details of the Acquisition Name of the Target Company (TC) Novartis India Limited Target Company Name(s) of the acquirer and Persons Acting in Acquirer 1 Concert (PAC) with the acquirer ChrysCapital Fund X, the first scheme of ChrysCapital Trust I, a category II alternative investment fund Acquirer 2 Acquirer 3 Acquirers PAC 1 PAC 2 PACs . Whether the acquirer belongs to Prior to the acquisition, none of the Acquirers or PACs Promoter / Promoter group belong to the promoter/ promoter group of the Target Company. Post the acquisition, Acquirer 1 and Acquirer 2 are in control of the Target Company and have become promoters of the Target Company. Further, the shareholding of Acquirer 3 shall be included as part of Company and Acquirer 3 shall be classified as a Company. Name(s) of the Stock Exchange(s) where BSE Limited the shares of TC are Listed Details of the acquisition as follows Number % w.r.t.total % w.r.t. total share/voting diluted capital share/voting wherever capital of the applicable (*) TC (**) Before the acquisition under consideration, holding of acquirer along with PACs of: a) Shares carrying voting rights a) Please see a) Please see a) Please see below: below: below: Acquirer 1: Nil Acquirer 1: Nil Acquirer 1: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 3: 40 Acquirer 3: Acquirer 3: PAC 1: Nil Nominal Nominal b) Shares in the nature of encumbrance PAC 2: Nil PAC 1: Nil PAC 1: Nil (pledge/ lien/ non-disposal undertaking/ PAC 2: Nil PAC 2: Nil others) c) Voting rights (VR) otherwise than by shares b) Please see b) Please see b) Please see d) Warrants/convertible securities/any other below: below: below: instrument that entitles the acquirer to receive shares carrying voting rights in the Acquirer 1: Nil Acquirer 1: Nil Acquirer 1: Nil TC (specify holding in each category) Acquirer 2: Nil Acquirer 2: Nil Acquirer 2: Nil e) Total (a+b+c+d) Acquirer 3: Nil Acquirer 3: Nil Acquirer 3: Nil PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil c) Please see c) Please see c) Please see below: below: below: Acquirer 1: Nil Acquirer 1: Nil Acquirer 1: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 3: Nil Acquirer 3: Nil Acquirer 3: Nil PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil d) Please see d) Please see d) Please see below: below: below: Acquirer 1: Nil Acquirer 1: Nil Acquirer 1: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 3: Nil Acquirer 3: Nil Acquirer 3: Nil PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil e) Total: e) Total: e) Total: Acquirer 1: Nil Acquirer 1: Nil Acquirer 1: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 3: 40 Acquirer 3: Acquirer 3: PAC 1: Nil Nominal Nominal PAC 2: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil Details of acquisition a) Shares carrying voting rights acquired a) Please see a) Please see a) Please see b) VRs acquired otherwise than by equity below: below: below: shares Acquirer 1: Acquirer 1: Acquirer 1: c) Warrants/convertible securities/any other 1,39,38,382 56.45% 56.45% instrument that entitles the acquirer to Acquirer 2: Acquirer 2: Acquirer 2: receive shares carrying voting rights in 25,47,189 10.32% 10.32% the TC (specify Acquirer 3: Acquirer 3: Acquirer 3: holding in each category) acquired 9,65,109 3.91% 3.91% PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil b) Please see b) Please see b) Please see below: below: below: Acquirer 1: Nil Acquirer 1: Nil Acquirer 1: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 3: Nil Acquirer 3: Nil Acquirer 3: Nil PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil c) Please see c) Please see c) Please see below: below: below: Acquirer 1: Nil Acquirer 1: Nil Acquirer 1: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 3: Nil Acquirer 3: Nil Acquirer 3: Nil PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil d) Shares in the nature of encumbrance d) Please see d) Please see d) Please see (pledge/ lien/ non-disposal undertaking/ below: below: below: others) e) Total (a+b+c+/-d) Acquirer 1: Nil Acquirer 1: Nil Acquirer 1: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 3: Nil Acquirer 3: Nil Acquirer 3: Nil PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil e) Total: e) Total: e) Total: Acquirer 1: Acquirer 1: Acquirer 1: 1,39,38,382 56.45% 56.45% Acquirer 2: Acquirer 2: Acquirer 2: 25,47,189 10.32% 10.32% Acquirer 3: Acquirer 3: Acquirer 3: 3.91% 9,65,109 3.91% PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil After the acquisition, holding of acquirer along with PACs of: a) Shares carrying voting rights a) Please see a) Please see a) Please see b) VRs otherwise than by equity shares below: below: below: c) Warrants/convertible securities Acquirer 1: Acquirer 1: Acquirer 1: /any other instrument that entitles the 1,39,38,382 56.45% 56.45% acquirer to receive shares carrying Acquirer 2: Acquirer 2: Acquirer 2: voting rights in the TC (specify holding 25,47,189 10.32% 10.32% in each category) after acquisition Acquirer 3: Acquirer 3: Acquirer 3: 3.91% d) Shares in the nature of encumbrance 9,65,149 3.91% PAC 1: Nil (pledge/ lien/ non-disposal PAC 1: Nil PAC 1: Nil PAC 2: Nil undertaking/ others) PAC 2: Nil PAC 2: Nil e) Total (a+b+c+d) b) Please see b) Please see b) Please see below: below: below: Acquirer 1: Nil Acquirer 1: Nil Acquirer 1: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 3: Nil Acquirer 3: Nil Acquirer 3: Nil PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil c) Please see c) Please see c) Please see below: below: below: Acquirer 1: Nil Acquirer 1: Nil Acquirer 1: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 3: Nil Acquirer 3: Nil Acquirer 3: Nil PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil d) Please see d) Please see d) Please see below: below: below: Acquirer 1: Nil Acquirer 1: Nil Acquirer 1: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 2: Nil Acquirer 3: Nil Acquirer 3: Nil Acquirer 3: Nil PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil e) Total: e) Total: e) Total: Acquirer 1: Acquirer 1: Acquirer 1: 1,39,38,382 56.45% 56.45% Acquirer 2: Acquirer 2: Acquirer 2: 25,47,189 10.32% 10.32% Acquirer 3: Acquirer 3: Acquirer 3: 3.91% 9,65,149 3.91% PAC 1: Nil PAC 1: Nil PAC 1: Nil PAC 2: Nil PAC 2: Nil PAC 2: Nil Mode of acquisition (e.g. open market / public Off-market Transfer issue / rights issue / preferential allotment / inter-se transfer / encumbrance, etc.) Salient features of the securities acquired N.A. including time till redemption, ratio at which it can be converted into equity shares, etc. Date of acquisition of / date of receipt of July 29, 2026 intimation of allotment of shares / VR/ warrants/convertible securities/any other instrument that entitles the acquirer to receive shares in the TC. Equity share capital / total voting capital of the INR 12,34,53,985 comprising of 2,46,90,797 fully TC before the said acquisition paid-up equi [Showing first 8,000 characters — download PDF for full document]